Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Non-invasive, continuous monitoring of a vascular targeting drug by diffuse optical blood flow and blood oxygenation measurements

Not Accessible

Your library or personal account may give you access

Abstract

Here we present a pilot study on vascular targeting drug combretastatin A4- phosphate (CA4P) in K1735 malignant melanoma tumor models. The results show that CA4P induces a drastic decrease in blood flow and oxygen saturation. These results correlated well with contrast enhanced Ultrasound and nitroimidazole (EF5) binding.

© 2006 Optical Society of America

PDF Article
More Like This
Changes in optical blood flow and oxygenation of head and neck tumors during chemo-radiation therapy

Ulaş Sunar, H. Quon, J. Zhang, J. Du, T. Durduran, C. Zhou, G. Yu, A. Kilger, R. Lustig, L. Loevner, S. Nioka, B. Chance, and A. G. Yodh
MI7 Biomedical Topical Meeting (BIOMED) 2006

Ranpirnase enhances efficacy of radiation on A549 human lung cancer xenografts of nude mice assessed by diffuse optical spectroscopies

Ula¸s Sunar, Chao Zhou, Turgut Durduran, Guoqiang Yu, Arjun G. Yodh, and Intae Lee
TuI10 Biomedical Topical Meeting (BIOMED) 2006

Monitoring of radiation therapy response of head and neck tumors by non-invasive optical blood flow measurements

U. Sunar, H. Quon, J. Zhangt, J. Du, T. Durduran, C. Zhou, G. Yu, A. Kilger, R. Lustig, L. Loevner, S. Nioka, A.G. Yodh, and B. Chance
WE1 European Conference on Biomedical Optics (ECBO) 2005

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.